This medicine, Larotrectinib, is a TRK inhibitor. It’s made to zero in on NTRK gene fusions in cancerous tumors. It really zeros in on TRKA, TRKB, and TRKC, which helps stop tumor growth.
This drug is meant to treat NTRK-fusion-positive cancers that can’t be removed or have spread to other parts of the body, for both adults and kids. You can get it in 25 mg and 100 mg capsules, plus a 20 mg per mL liquid you take by mouth. For adults, it’s usually 100 mg taken twice a day.
For kids, it depends on their body size. The stuff comes in bottles, each with 60 capsules.